Literature DB >> 19249289

Domain 3 of non-structural protein 5A from hepatitis C virus is natively unfolded.

Xavier Hanoulle1, Dries Verdegem, Aurélie Badillo, Jean-Michel Wieruszeski, François Penin, Guy Lippens.   

Abstract

Hepatitis C virus (HCV) non-structural protein 5A (NS5A) is involved both in the viral replication and particle production. Its third domain (NS5A-D3), although not absolutely required for replication, is a key determinant for the production and assembly of novel HCV particles. As a prerequisite to elucidate the precise functions of this domain, we report here the first molecular characterization of purified recombinant HCV NS5A-D3. Sequence analysis indicates that NS5A-D3 is mostly unstructured but that short structural elements may exist at its N-terminus. Gel filtration chromatography, circular dichroism and finally NMR spectroscopy all point out the natively unfolded nature of purified recombinant NS5A-D3. This lack of stable folding is thought to be essential for primary interactions of NS5A-D3 domain with other viral or host proteins, which could stabilize some specific conformations conferring new functional features.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19249289     DOI: 10.1016/j.bbrc.2009.02.108

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  42 in total

1.  Expanding the proteome of an RNA virus by phosphorylation of an intrinsically disordered viral protein.

Authors:  Daniel G Cordek; Tayler J Croom-Perez; Jungwook Hwang; Michele R S Hargittai; Chennareddy V Subba-Reddy; Qingxia Han; Maria Fernanda Lodeiro; Gang Ning; Thomas S McCrory; Jamie J Arnold; Hasan Koc; Brett D Lindenbach; Scott A Showalter; Craig E Cameron
Journal:  J Biol Chem       Date:  2014-07-16       Impact factor: 5.157

2.  Resistance analysis of the hepatitis C virus NS5A inhibitor BMS-790052 in an in vitro replicon system.

Authors:  Robert A Fridell; Dike Qiu; Chunfu Wang; Lourdes Valera; Min Gao
Journal:  Antimicrob Agents Chemother       Date:  2010-06-28       Impact factor: 5.191

3.  TARGETING THE NS5A PROTEIN OF HCV: AN EMERGING OPTION.

Authors:  D G Cordek; J T Bechtel; A T Maynard; W M Kazmierski; C E Cameron
Journal:  Drugs Future       Date:  2011-09       Impact factor: 0.148

Review 4.  Resistance detection and re-treatment options in hepatitis C virus-related chronic liver diseases after DAA-treatment failure.

Authors:  Evangelista Sagnelli; Mario Starace; Carmine Minichini; Mariantonietta Pisaturo; Margherita Macera; Caterina Sagnelli; Nicola Coppola
Journal:  Infection       Date:  2018-08-06       Impact factor: 3.553

Review 5.  Daclatasvir-containing all-oral regimens for the treatment of hepatitis C virus infection.

Authors:  Sheng-Shun Yang; Jia-Horng Kao
Journal:  Hepatol Int       Date:  2015-11-05       Impact factor: 6.047

6.  Fluorescence resonance energy transfer-based intracellular assay for the conformation of hepatitis C virus drug target NS5A.

Authors:  Dipankar Bhattacharya; Israrul H Ansari; Andrew Mehle; Rob Striker
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

7.  A conserved tandem cyclophilin-binding site in hepatitis C virus nonstructural protein 5A regulates Alisporivir susceptibility.

Authors:  Henry Grisé; Stephen Frausto; Timothy Logan; Hengli Tang
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

8.  Cyclophilin A allows the allosteric regulation of a structural motif in the disordered domain 2 of NS5A and thereby fine-tunes HCV RNA replication.

Authors:  Marie Dujardin; Vanesa Madan; Neha S Gandhi; François-Xavier Cantrelle; Hélène Launay; Isabelle Huvent; Ralf Bartenschlager; Guy Lippens; Xavier Hanoulle
Journal:  J Biol Chem       Date:  2019-07-17       Impact factor: 5.157

9.  Domain 3 of NS5A protein from the hepatitis C virus has intrinsic alpha-helical propensity and is a substrate of cyclophilin A.

Authors:  Dries Verdegem; Aurélie Badillo; Jean-Michel Wieruszeski; Isabelle Landrieu; Arnaud Leroy; Ralf Bartenschlager; François Penin; Guy Lippens; Xavier Hanoulle
Journal:  J Biol Chem       Date:  2011-04-13       Impact factor: 5.157

10.  Hepatitis C virus nonstructural protein 5A: biochemical characterization of a novel structural class of RNA-binding proteins.

Authors:  Jungwook Hwang; Luyun Huang; Daniel G Cordek; Robert Vaughan; Shelley L Reynolds; George Kihara; Kevin D Raney; C Cheng Kao; Craig E Cameron
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.